optic pathway glioma
optic pathway glioma
Explore linked clinical trials. Standard reference: MONDO:00161674 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), diffuse astrocytoma, epithelial neoplasm, ganglioglioma, glioma, neoplasm, neuroepithelial neoplasm, optic pathway glioma, pilocytic astrocytoma, pilomyxoid astrocytoma, primitive neuroectodermal tumor | Active, not recruiting | Not applicable | 2026-09-15 | NCT04065776 | |
| China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Rathke Cleft Cysts, brain disorder, central nervous system cancer, central nervous system cyst, central nervous system disorder, central nervous system malformation, chordoma, craniopharyngioma, germinoma, hypothalamic disorder, hypothalamic neoplasm, meningioma, neoplasm, nervous system disorder, optic pathway glioma, primitive neuroectodermal tumor, supratentorial cancer, tumor of meninges, vascular cancer | Not yet recruiting | Not stated | 2026-09-09 | NCT07809178 | |
| A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, low grade glioma, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neurofibroma, neurofibromatosis, neurofibromatosis type 1, neuromuscular disease, optic pathway glioma, peripheral nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-13 | NCT03871257 | |
| Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, central nervous system malformation, cranial nerve neuropathy, eye disorder, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, optic atrophy, optic nerve disorder, optic pathway glioma, peripheral nervous system disorder, polyneuropathy | Active, not recruiting | Phase 2 | 2026-03-19 | NCT05733572 |